Not all employers have the luxury of taking the long view when it comes to GLP-1s, though, Dam noted
"This makes it important for Part D and Medicare Advantage enrollees to comparison shop each year during the fall enrollment period, to see if their current medications might be better covered under a different plan," Norris said.
Manufacturers have recently rolled out cash-pay options that lower the price substantially (for example, self-pay around $349 a month), but the core drivers (exclusivity, demand, and the US system) keep list prices high
The dramatic weight-loss properties of current medications are largely attributed to GLP-1 agonism in these brain regions, to increase feelings of satiety and reduce food intake
That's the promise behind the glow stack peptide, a combination that's captured the attention of researchers, biohackers, and anyone tired of surface-level skincare solutions
Whether at-home microinfusion is the highest-value allocation of skincare spend depends on the rest of the routine